Safiqa Hossain of DOT
[2] Effective results have been found in clinical trials of Beacon Pharmaceuticals’ Favipiravir for the treatment of patients infected with coronavirus. In Dhaka, 96 percent of the patients recovered from the Covid-19 infection. Bangladesh Medicine Society (BSM) conducted the trial, reports Sarabangl.net.
[3] The results of the clinical trial were announced by Syed Golam Magni Maula at a seminar held at Westin Hotel in Dhaka yesterday (July 8).
[4] He presented all the information on the seminar titled ‘Testing the Effectiveness of Favipiravir Drugs on Patients in Bangladesh Hospitals’. The seminar was organized by Beacon Pharmaceuticals Limited.